Troy A. Ignelzi, Chief Financial Officer at Rapport Therapeutics, Inc. (RAPP), bought 10,000 shares at $10.10 ($101K) on 2025-03-12, disclosed to the SEC on 2025-03-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.10 | 9,900 | $100K | 99.0% |
| 2 | $9.98 | 100 | $998 | 1.0% |
| Total | $10.10 avg | 10,000 | $101K | 100% |
| Filing → |
| KRTX | SELL | 2023-02-23 | $1.1M | — | Filing → |
| KRTX | SELL | 2023-01-19 | $369K | — | Filing → |
| KRTX | SELL | 2022-11-17 | $3.7M | — | Filing → |